What biomarkers can reliably measure real-time glymphatic function to guide sleep-based neurodegeneration therapies?

biomarker-development open
Open a bounty challenge Fund this gap and accept submissions. SPEC-033.
Composite
—
Novelty
—
Mechanistic
—
Druggability
—
Priority
75%
Importance
—
Tractability
—
Market price
50%

Description

The debate emphasized the need for precision timing and monitoring of glymphatic clearance, but no validated biomarkers for real-time assessment were identified. This represents a critical gap for translating sleep therapies to clinical practice.

Source: Debate session sess_sda-2026-04-01-gap-v2-18cf98ca (Analysis: sda-2026-04-01-gap-v2-18cf98ca)